BioSpace News Archive

Florida Cancer Specialists & Research Institute, LLC welcomes Board-certified hematologist and medical oncologist Pavankumar Tandra, MD to the statewide practice.

Matinas BioPharma (NYSE AMER: MTNB, Matinas), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology, today is providing a business update on its ongoing programs and discussing its strategic outlook for 2023.

scPharmaceuticals Inc. (Nasdaq: SCPH), today announced that the company is targeting February 20, 2023 as the date for commercial availability of FUROSCIX® (furosemide injection), a proprietary formulation of furosemide delivered via an On-Body Infusor for outpatient treatment of congestion due to fluid overload in adult patients with New York Heart Association (NYHA) Class II and Class III chronic heart failure.

Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”) announced today that it will host an investor conference call and webcast to provide a corporate update on Tuesday, January 31 from 8:30 am – 9:30 am Eastern Time.

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that its Board of Directors has appointed Joseph H. Capper as the Company’s Chief Executive Officer and a director of the Company, effective immediately.

Immutep Limited, a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, provides an update on the ongoing development of its product candidates, efti and IMP761, for the quarter ended 31 December 2022.

Smith+Nephew (LSE:SN, NYSE:SNN) today announces that its LEAF Patient Monitoring System has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the United States. Smith+Nephew exhibited the LEAF Patient Monitoring System at the Vizient Innovative Technology Exchange on October 17th in Dallas, Texas.

Renibus Therapeutics® today announced that company management will participate in the SVB Securities Global Biopharma Conference, taking place virtually from January 31, 2023- February 16 , 2023.

Advanced Medaesthetic Partners announced its newly formed C-Suite, comprised of Founder and Chief Executive Officer Nicole Chiaramonte, Chief Commercial Officer Drew Fine, Chief Operating Officer Brett Erreca and General Counsel Renee Coover.

Alto Neuroscience Inc. today announced a $25 million equity investment by new investor, Alpha Wave Ventures.